1. RAND Corporation. Biosimilar drugs could generate $38.4 billion in savings over five years. https://www.rand.org/news/press/2022/01/10.html (10 January 2022).
2. Committee on Oversight and Reform, US House of Representatives. Drug Pricing Investigation: Majority Staff Report https://oversightdemocrats.house.gov/sites/democrats.oversight.house.gov/files/DRUG%20PRICING%20REPORT%20WITH%20APPENDIX%20v3.pdf (2021).
3. Goode, R. & Chao, B. H. J. Law Biosci. 9, 1–24 (2022).
4. Rai, A. K. et al. Berkeley Technol. Law J. 37, 101–130 (2022).
5. Van de Wiele, V. L., Kesselheim, A. S. & Sarpatwari, A. Health Aff. (Millwood) 40, 1198–1205 (2021).